Pharmaceutical companies expanding into new markets regularly encounter payment infrastructure gaps. Acquirers decline applications based on product classification. Banking partners impose restrictive covenants tied to jurisdictional exposure. Multi-currency settlement becomes fragile as group structures grow more complex.
We advise pharmaceutical businesses on structuring financial infrastructure that accommodates international operations, complex group structures, and the specific institutional concerns that arise from operating in a highly regulated supply chain.
Biotech and life sciences companies face a particular challenge: extended pre-revenue periods, capital-intensive R&D, and a risk profile that shifts significantly as the business moves from research through clinical trials to commercialisation. Financial institutions often struggle to underwrite businesses whose operating model changes materially at each stage.
We advise on financial infrastructure that evolves with the business — structured to meet institutional expectations at each stage of development, from early funding rounds through to commercial-scale operations.
Licensed medicinal cannabis businesses face the most acute version of the problem we solve. Despite full regulatory compliance, financial institutions routinely decline applications, terminate existing relationships, or impose conditions that make normal business operations impossible. Legacy risk perceptions persist even as regulatory frameworks mature.
We have extensive experience advising licensed operators across cultivation, manufacturing, distribution, and ancillary services. We understand what institutions need to see — and what triggers their concerns — because we’ve navigated these conversations many times.
We selectively advise businesses in other regulated or complex industries where financial access requires specialist consideration. If your business is legitimate, licensed, and struggling with financial infrastructure that doesn’t reflect your actual risk profile, we may be able to help.
These engagements are assessed individually to ensure alignment between your requirements and our expertise.
Copyright © 2026 Paytiva - All Rights Reserved.
Paytiva Limited is a consultancy and not a bank or payment provider. The services referenced are provided by approved third-party partners that are appropriately licensed.
Clients enter into separate and direct agreements with such partners. Paytiva Limited is not responsible or liable for any loss or damages arising from services provided by third parties.